Efficacy and Safety of RAdiofrequency Versus HAL- RAR DOppler in Hemorrhoidal Pathology
Sponsored by Elsan
About this trial
Last updated 2 years ago
Study ID
Status
Type
Phase
Placebo
Accepting
Not accepting
Trial Timing
Ended a month ago
What is this trial about?
What are the participation requirements?
Inclusion Criteria
- Male or Female consulting for hemorrhoidal pathology (grade II or III) after failure of medico-instrumental treatments.
- Age ≥ 18 years and < 75 years
- Mandatory affiliation to a health insurance system.
- Patient having been informed of the study and having given informed consent
Exclusion Criteria
- Patients with chronic inflammatory bowel disease
- Patients with suspected gastro-colic pathology
- Haematological diseases
- Anal fistulas
- Patients unable to discontinue anti-vitamin K or oral anticoagulants
- Associated anal fissure
- External haemorrhoidal disease
- Pregnant or breastfeeding women
- Patients under legal protection